Search

Find exactly what you’re looking for.
Search

Showing 241-247 of 247 results

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act. By Melissa Schiller Jonathan Havens, co-chair of the Cannabis...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, and co-chair of the Firm's Food, Beverage and Agribusiness Practice, spoke at the Food and Drug Law Institute's 2022 Legal and Practical Issues in Cannabis Regulation Conference on May 25, 2022. Jonathan's topic was "Facilitating...

FACILITATING STAKEHOLDER COLLABORATION TO IMPROVE FUTURE CANNABIS REGULATION Jonathan Havens, Co-Chair of the Firm's Cannabis Law Practice, and Co-Chair of the Firm's Food, Beverage and Agribusiness Practice, will be speaking at the Food and Drug Law Institute's 2022 Legal and Practical Issues in...

AstraZeneca’s ambitious vaccine dreams are finally, officially dead One major caveat: even if the bill passes, it would be up to the FDA to decide when to crack down — and not everyone is convinced they will. “I’m, for one, a bit skeptical that this would immediately change [things] too much, unless...

Saul Ewing's Environmental, Social, and Governance Practice and the Home Builders Association of Greater Chicago conducted a panel discussion of industry experts providing an overview of SEC Proposed Rule S7-10-22 regarding climate risk. In addition to a general overview, presenters discussed...

Saul Ewing LLP served as counsel to Marwin II, LLC, a wholly owned subsidiary of US Wind, Inc., in the application to the Maryland Public Service Commission for, and approval of, approximately 800 megawatts of Maryland Offshore Renewable Energy Credits ("ORECs"). The addition of the extra 800...

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp. , lead underwriter of an overnight marketed...

For More Information
Contact us